Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sarepta Therapeutics Inc (NASDAQ:SRPT)

47.10
Delayed Data
As of 4:00pm ET
 +0.37 / +0.79%
Today’s Change
26.26
Today|||52-Week Range
63.73
+71.71%
Year-to-Date
No recent news for Sarepta Therapeutics Inc.

Today’s Trading

Previous close46.73
Today’s open46.50
Day’s range45.95 - 47.28
Volume1,222,654
Average volume (3 months)2,319,167
Market cap$3.0B
Dividend yield--
Data as of 4:00pm ET, 09/21/2017

Growth & Valuation

Earnings growth (last year)-5.58%
Earnings growth (this year)+77.62%
Earnings growth (next 5 years)+0.37%
Revenue growth (last year)+332.64%
P/E ratioNM
Price/Sales246.40
Price/Book7.60

Competitors

 Today’s
change
Today’s
% change
CBPOChina Biologic Produ...-2.95-3.18%
LOXOLoxo Oncology Inc-0.43-0.48%
RAREUltragenyx Pharmaceu...-0.11-0.21%
IRWDIronwood Pharmaceuti...+0.10+0.65%
Data as of 4:00pm ET, 09/21/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$0.92
Annual revenue (last year)$5.4M
Annual profit (last year)-$267.3M
Net profit margin-4,930.18%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Douglas S. Ingram
Executive VP, Chief Financial &
Business Officer
Sandesh Mahatme
Corporate headquarters
Cambridge, Massachusetts

Forecasts